133 related articles for article (PubMed ID: 15708529)
21. Interference RNA technology in the treatment of CNV.
Tolentino M
Ophthalmol Clin North Am; 2006 Sep; 19(3):393-9, vi-vii. PubMed ID: 16935214
[TBL] [Abstract][Full Text] [Related]
22. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.
Zhang GY; Yi CG; Li X; Zheng Y; Niu ZG; Xia W; Meng Z; Meng CY; Guo SZ
Arch Dermatol Res; 2008 Apr; 300(4):177-84. PubMed ID: 18239926
[TBL] [Abstract][Full Text] [Related]
24. [Progress in silencing HBV gene expression by RNAi technologies].
Tang N; Huang AL
Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):318-20. PubMed ID: 16635316
[No Abstract] [Full Text] [Related]
25. Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials.
Thomas M; Greil J; Heidenreich O
Acta Pharmacol Sin; 2006 Mar; 27(3):273-81. PubMed ID: 16490161
[TBL] [Abstract][Full Text] [Related]
26. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
[TBL] [Abstract][Full Text] [Related]
27. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
Sun X; Rogoff HA; Li CJ
Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of RNA interference for neurological disorders.
Sah DW
Life Sci; 2006 Oct; 79(19):1773-80. PubMed ID: 16815477
[TBL] [Abstract][Full Text] [Related]
29. [RNA interference and molecular pathology of selected diseases].
Lochmanová J; Bartos M
Cas Lek Cesk; 2008; 147(12):607-15. PubMed ID: 19235485
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic RNA interference for neurodegenerative diseases].
González-Alegre P
Rev Neurol; 2008 Dec 16-31; 47(12):641-7. PubMed ID: 19085881
[TBL] [Abstract][Full Text] [Related]
31. Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma.
Koldehoff M; Beelen DW; Elmaagacli AH
J Leukoc Biol; 2008 Aug; 84(2):561-76. PubMed ID: 18458152
[TBL] [Abstract][Full Text] [Related]
32. RNA interference as an anticancer therapy: a patent perspective.
Dykxhoorn DM
Expert Opin Ther Pat; 2009 Apr; 19(4):475-91. PubMed ID: 19441927
[TBL] [Abstract][Full Text] [Related]
33. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
34. Blocking cancer with RNA interference moves toward the clinic.
Hede K
J Natl Cancer Inst; 2005 May; 97(9):626-8. PubMed ID: 15870429
[No Abstract] [Full Text] [Related]
35. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma.
Kim WJ; Christensen LV; Jo S; Yockman JW; Jeong JH; Kim YH; Kim SW
Mol Ther; 2006 Sep; 14(3):343-50. PubMed ID: 16765648
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic possibilities of interference RNA.
López Tricas JM
Farm Hosp; 2012; 36(3):115-7. PubMed ID: 22137610
[No Abstract] [Full Text] [Related]
37. [Application of RNAi to cancer therapy].
Tan YL; Yin JQ
Yao Xue Xue Bao; 2005 Mar; 40(3):193-8. PubMed ID: 15952587
[No Abstract] [Full Text] [Related]
38. Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF).
Murata M; Takanami T; Shimizu S; Kubota Y; Horiuchi S; Habano W; Ma JX; Sato S
Curr Eye Res; 2006 Feb; 31(2):171-80. PubMed ID: 16500768
[TBL] [Abstract][Full Text] [Related]
39. Exploring in vitro roles of siRNA in cardiovascular disease.
Tang Y; Ge YZ; Yin JQ
Acta Pharmacol Sin; 2007 Jan; 28(1):1-9. PubMed ID: 17184576
[TBL] [Abstract][Full Text] [Related]
40. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
